0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Celiac Disease Treatment Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

  • PDF Icon

    Report

  • 82 Pages
  • May 2025
  • Region: Global
  • Prof Research
  • ID: 6090509
Celiac disease treatments include vitamins, gluten-degrading enzymes, and symptomatic therapies to manage a chronic autoimmune disorder affecting 1% of the global population, with diagnosis rates rising from 10% in 2000 to 30% in 2020. The market is driven by increasing nutritional health awareness, with 60% of consumers prioritizing gluten-free diets, and advancements in drug development, such as larazotide acetate, which improves symptoms in 30% of patients. The aging population, improved diagnostics, and rising prevalence of autoimmune diseases further boost demand. The global celiac disease treatment market is estimated at USD 400-700 million in 2025, with a CAGR of 8%-13% through 2030.

Regional Market Trends

  • North America: The U.S. leads with high diagnosis rates and gluten-free product adoption, while Canada focuses on dietary management.
  • Europe: Germany, France, and the UK drive growth with robust gastroenterology services.
  • Asia Pacific: China and India see rising demand due to increasing awareness, with Japan emphasizing novel therapies.
  • Rest of the World: Brazil expands public health access, while the Middle East addresses dietary health.

Distribution Channel Analysis

  • Hospital Pharmacies: Expected growth of 8.5%-13.5%, driven by symptomatic treatments. Trends focus on specialized care.
  • Retail Pharmacies: Projected growth of 8.2%-13.2%, linked to vitamins and enzymes. Advances emphasize patient convenience.
  • Other Distribution Channels: Anticipated growth of 7.8%-12.8%, covering online platforms. Trends highlight digital access.

Type Analysis

  • Vitamins & Minerals: Expected growth of 8.0%-13.0%, valued for nutritional support. Trends focus on fortified supplements.
  • Gluten Degrading Enzymes: Projected growth of 9.0%-14.0%, favored for dietary management. Advances emphasize oral formulations.
  • Symptomatic Treatment (Anti-inflammatory Drugs, Antihistamines, Others): Anticipated growth of 7.8%-12.8%, suited for symptom relief. Trends highlight combination therapies.
  • Other Treatments: Expected growth of 7.5%-12.5%, covering novel drugs. Developments prioritize gut barrier restoration.

Key Market Players

  • Teva Pharmaceutical: Offers symptomatic treatments for celiac disease.
  • Amgen: Develops novel therapies for autoimmune disorders.
  • Takeda Pharmaceutical: Focuses on gastrointestinal treatments.
  • Novartis: Provides anti-inflammatory drugs.
  • BioLineRx: Specializes in innovative celiac therapies.

Porter’s Five Forces Analysis

  • Threat of New Entrants: Moderate, due to high R&D costs, but dietary supplements lower barriers.
  • Threat of Substitutes: High, with gluten-free diets competing, but drugs address severe cases.
  • Bargaining Power of Buyers: Moderate, as patients seek effective therapies, but dietary options limit choices.
  • Bargaining Power of Suppliers: Low, with multiple providers of active ingredients.
  • Competitive Rivalry: Moderate, with players competing on efficacy and accessibility.

Market Opportunities and Challenges

Opportunities:

  • Addressing celiac disease, affecting 1% of the population.
  • Leveraging rising diagnosis rates, up to 30% in 2020.
  • Utilizing nutritional health awareness, with 60% consumer focus.
  • Supporting novel drugs like larazotide acetate.
  • Meeting demand from aging populations with autoimmune risks.
  • Expanding gluten-free product access in emerging markets.

Challenges:

  • High costs of novel therapies.
  • Regulatory delays for new drugs.
  • Patient adherence to gluten-free diets.
  • Competition from dietary management.
  • Limited awareness in low-income regions.

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1 Executive SummaryChapter 2 Abbreviation and Acronyms
Chapter 3 Preface
3.1 Research Scope
3.2 Research Sources
3.2.1 Data Sources
3.2.2 Assumptions
3.3 Research Method
Chapter 4 Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users
Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
Chapter 6 Industry Chain Analysis
6.1 Upstream/Suppliers Analysis
6.2 Celiac Disease Treatment Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users
Chapter 7 Latest Market Dynamics
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics
Chapter 8 Historical and Forecast Celiac Disease Treatment Market in North America (2020-2030)
8.1 Celiac Disease Treatment Market Size
8.2 Celiac Disease Treatment Market by End Use
8.3 Competition by Players/Suppliers
8.4 Celiac Disease Treatment Market Size by Type
8.5 Key Countries Analysis
8.5.1 United States
8.5.2 Canada
8.5.3 Mexico
Chapter 9 Historical and Forecast Celiac Disease Treatment Market in South America (2020-2030)
9.1 Celiac Disease Treatment Market Size
9.2 Celiac Disease Treatment Market by End Use
9.3 Competition by Players/Suppliers
9.4 Celiac Disease Treatment Market Size by Type
9.5 Key Countries Analysis
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Chile
9.5.4 Peru
Chapter 10 Historical and Forecast Celiac Disease Treatment Market in Asia & Pacific (2020-2030)
10.1 Celiac Disease Treatment Market Size
10.2 Celiac Disease Treatment Market by End Use
10.3 Competition by Players/Suppliers
10.4 Celiac Disease Treatment Market Size by Type
10.5 Key Countries Analysis
10.5.1 China
10.5.2 India
10.5.3 Japan
10.5.4 South Korea
10.5.5 Southeast Asia
10.5.6 Australia
Chapter 11 Historical and Forecast Celiac Disease Treatment Market in Europe (2020-2030)
11.1 Celiac Disease Treatment Market Size
11.2 Celiac Disease Treatment Market by End Use
11.3 Competition by Players/Suppliers
11.4 Celiac Disease Treatment Market Size by Type
11.5 Key Countries Analysis
11.5.1 Germany
11.5.2 France
11.5.3 United Kingdom
11.5.4 Italy
11.5.5 Spain
11.5.6 Belgium
11.5.7 Netherlands
11.5.8 Austria
11.5.9 Poland
11.5.10 Russia
Chapter 12 Historical and Forecast Celiac Disease Treatment Market in MEA (2020-2030)
12.1 Celiac Disease Treatment Market Size
12.2 Celiac Disease Treatment Market by End Use
12.3 Competition by Players/Suppliers
12.4 Celiac Disease Treatment Market Size by Type
12.5 Key Countries Analysis
12.5.1 Egypt
12.5.2 Israel
12.5.3 South Africa
12.5.4 Gulf Cooperation Council Countries
12.5.5 Turkey
Chapter 13 Summary For Global Celiac Disease Treatment Market (2020-2025)
13.1 Celiac Disease Treatment Market Size
13.2 Celiac Disease Treatment Market by End Use
13.3 Competition by Players/Suppliers
13.4 Celiac Disease Treatment Market Size by Type
Chapter 14 Global Celiac Disease Treatment Market Forecast (2025-2030)
14.1 Celiac Disease Treatment Market Size Forecast
14.2 Celiac Disease Treatment Application Forecast
14.3 Competition by Players/Suppliers
14.4 Celiac Disease Treatment Type Forecast
Chapter 15 Analysis of Global Key Vendors
15.1 Teva Pharmaceutical
15.1.1 Company Profile
15.1.2 Main Business and Celiac Disease Treatment Information
15.1.3 SWOT Analysis of Teva Pharmaceutical
15.1.4 Teva Pharmaceutical Celiac Disease Treatment Revenue, Gross Margin and Market Share (2020-2025)
15.2 Amgen
15.2.1 Company Profile
15.2.2 Main Business and Celiac Disease Treatment Information
15.2.3 SWOT Analysis of Amgen
15.2.4 Amgen Celiac Disease Treatment Revenue, Gross Margin and Market Share (2020-2025)
15.3 Amneal Pharmaceuticals
15.3.1 Company Profile
15.3.2 Main Business and Celiac Disease Treatment Information
15.3.3 SWOT Analysis of Amneal Pharmaceuticals
15.3.4 Amneal Pharmaceuticals Celiac Disease Treatment Revenue, Gross Margin and Market Share (2020-2025)
15.4 GLENMARK PHARMACEUTICALS
15.4.1 Company Profile
15.4.2 Main Business and Celiac Disease Treatment Information
15.4.3 SWOT Analysis of GLENMARK PHARMACEUTICALS
15.4.4 GLENMARK PHARMACEUTICALS Celiac Disease Treatment Revenue, Gross Margin and Market Share (2020-2025)
15.5 Takeda Pharmaceutical
15.5.1 Company Profile
15.5.2 Main Business and Celiac Disease Treatment Information
15.5.3 SWOT Analysis of Takeda Pharmaceutical
15.5.4 Takeda Pharmaceutical Celiac Disease Treatment Revenue, Gross Margin and Market Share (2020-2025)
15.6 Hikma Pharmaceuticals
15.6.1 Company Profile
15.6.2 Main Business and Celiac Disease Treatment Information
15.6.3 SWOT Analysis of Hikma Pharmaceuticals
15.6.4 Hikma Pharmaceuticals Celiac Disease Treatment Revenue, Gross Margin and Market Share (2020-2025)
15.7 Novartis
15.7.1 Company Profile
15.7.2 Main Business and Celiac Disease Treatment Information
15.7.3 SWOT Analysis of Novartis
15.7.4 Novartis Celiac Disease Treatment Revenue, Gross Margin and Market Share (2020-2025)
15.8 BioLineRx
15.8.1 Company Profile
15.8.2 Main Business and Celiac Disease Treatment Information
15.8.3 SWOT Analysis of BioLineRx
15.8.4 BioLineRx Celiac Disease Treatment Revenue, Gross Margin and Market Share (2020-2025)
List of Tables and Figures
Table Abbreviation and Acronyms
Table Research Scope of Celiac Disease Treatment Report
Table Data Sources of Celiac Disease Treatment Report
Table Major Assumptions of Celiac Disease Treatment Report
Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure Celiac Disease Treatment Picture
Table Celiac Disease Treatment Classification
Table Celiac Disease Treatment Applications
Table Drivers of Celiac Disease Treatment Market
Table Restraints of Celiac Disease Treatment Market
Table Opportunities of Celiac Disease Treatment Market
Table Threats of Celiac Disease Treatment Market
Table COVID-19 Impact For Celiac Disease Treatment Market
Table Raw Materials Suppliers
Table Different Production Methods of Celiac Disease Treatment
Table Cost Structure Analysis of Celiac Disease Treatment
Table Key End Users
Table Latest News of Celiac Disease Treatment Market
Table Merger and Acquisition
Table Planned/Future Project of Celiac Disease Treatment Market
Table Policy of Celiac Disease Treatment Market
Table 2020-2030 North America Celiac Disease Treatment Market Size
Figure 2020-2030 North America Celiac Disease Treatment Market Size and CAGR
Table 2020-2030 North America Celiac Disease Treatment Market Size by Application
Table 2020-2025 North America Celiac Disease Treatment Key Players Revenue
Table 2020-2025 North America Celiac Disease Treatment Key Players Market Share
Table 2020-2030 North America Celiac Disease Treatment Market Size by Type
Table 2020-2030 United States Celiac Disease Treatment Market Size
Table 2020-2030 Canada Celiac Disease Treatment Market Size
Table 2020-2030 Mexico Celiac Disease Treatment Market Size
Table 2020-2030 South America Celiac Disease Treatment Market Size
Figure 2020-2030 South America Celiac Disease Treatment Market Size and CAGR
Table 2020-2030 South America Celiac Disease Treatment Market Size by Application
Table 2020-2025 South America Celiac Disease Treatment Key Players Revenue
Table 2020-2025 South America Celiac Disease Treatment Key Players Market Share
Table 2020-2030 South America Celiac Disease Treatment Market Size by Type
Table 2020-2030 Brazil Celiac Disease Treatment Market Size
Table 2020-2030 Argentina Celiac Disease Treatment Market Size
Table 2020-2030 Chile Celiac Disease Treatment Market Size
Table 2020-2030 Peru Celiac Disease Treatment Market Size
Table 2020-2030 Asia & Pacific Celiac Disease Treatment Market Size
Figure 2020-2030 Asia & Pacific Celiac Disease Treatment Market Size and CAGR
Table 2020-2030 Asia & Pacific Celiac Disease Treatment Market Size by Application
Table 2020-2025 Asia & Pacific Celiac Disease Treatment Key Players Revenue
Table 2020-2025 Asia & Pacific Celiac Disease Treatment Key Players Market Share
Table 2020-2030 Asia & Pacific Celiac Disease Treatment Market Size by Type
Table 2020-2030 China Celiac Disease Treatment Market Size
Table 2020-2030 India Celiac Disease Treatment Market Size
Table 2020-2030 Japan Celiac Disease Treatment Market Size
Table 2020-2030 South Korea Celiac Disease Treatment Market Size
Table 2020-2030 Southeast Asia Celiac Disease Treatment Market Size
Table 2020-2030 Australia Celiac Disease Treatment Market Size
Table 2020-2030 Europe Celiac Disease Treatment Market Size
Figure 2020-2030 Europe Celiac Disease Treatment Market Size and CAGR
Table 2020-2030 Europe Celiac Disease Treatment Market Size by Application
Table 2020-2025 Europe Celiac Disease Treatment Key Players Revenue
Table 2020-2025 Europe Celiac Disease Treatment Key Players Market Share
Table 2020-2030 Europe Celiac Disease Treatment Market Size by Type
Table 2020-2030 Germany Celiac Disease Treatment Market Size
Table 2020-2030 France Celiac Disease Treatment Market Size
Table 2020-2030 United Kingdom Celiac Disease Treatment Market Size
Table 2020-2030 Italy Celiac Disease Treatment Market Size
Table 2020-2030 Spain Celiac Disease Treatment Market Size
Table 2020-2030 Belgium Celiac Disease Treatment Market Size
Table 2020-2030 Netherlands Celiac Disease Treatment Market Size
Table 2020-2030 Austria Celiac Disease Treatment Market Size
Table 2020-2030 Poland Celiac Disease Treatment Market Size
Table 2020-2030 Russia Celiac Disease Treatment Market Size
Table 2020-2030 MEA Celiac Disease Treatment Market Size
Figure 2020-2030 MEA Celiac Disease Treatment Market Size and CAGR
Table 2020-2030 MEA Celiac Disease Treatment Market Size by Application
Table 2020-2025 MEA Celiac Disease Treatment Key Players Revenue
Table 2020-2025 MEA Celiac Disease Treatment Key Players Market Share
Table 2020-2030 MEA Celiac Disease Treatment Market Size by Type
Table 2020-2030 Egypt Celiac Disease Treatment Market Size
Table 2020-2030 Israel Celiac Disease Treatment Market Size
Table 2020-2030 South Africa Celiac Disease Treatment Market Size
Table 2020-2030 Gulf Cooperation Council Countries Celiac Disease Treatment Market Size
Table 2020-2030 Turkey Celiac Disease Treatment Market Size
Table 2020-2025 Global Celiac Disease Treatment Market Size by Region
Table 2020-2025 Global Celiac Disease Treatment Market Size Share by Region
Table 2020-2025 Global Celiac Disease Treatment Market Size by Application
Table 2020-2025 Global Celiac Disease Treatment Market Share by Application
Table 2020-2025 Global Celiac Disease Treatment Key Vendors Revenue
Figure 2020-2025 Global Celiac Disease Treatment Market Size and Growth Rate
Table 2020-2025 Global Celiac Disease Treatment Key Vendors Market Share
Table 2020-2025 Global Celiac Disease Treatment Market Size by Type
Table 2020-2025 Global Celiac Disease Treatment Market Share by Type
Table 2025-2030 Global Celiac Disease Treatment Market Size by Region
Table 2025-2030 Global Celiac Disease Treatment Market Size Share by Region
Table 2025-2030 Global Celiac Disease Treatment Market Size by Application
Table 2025-2030 Global Celiac Disease Treatment Market Share by Application
Table 2025-2030 Global Celiac Disease Treatment Key Vendors Revenue
Figure 2025-2030 Global Celiac Disease Treatment Market Size and Growth Rate
Table 2025-2030 Global Celiac Disease Treatment Key Vendors Market Share
Table 2025-2030 Global Celiac Disease Treatment Market Size by Type
Table 2025-2030 Celiac Disease Treatment Global Market Share by Type

Companies Mentioned

  • Teva Pharmaceutical
  • Amgen
  • Amneal Pharmaceuticals
  • GLENMARK PHARMACEUTICALS
  • Takeda Pharmaceutical
  • Hikma Pharmaceuticals
  • Novartis
  • BioLineRx
This website uses cookies to ensure you get the best experience. Learn more